Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-553x|37|6|834-843

ISSN： 1751-5521

Source： International Journal Of Laboratory Hematology, Vol.37, Iss.6, 2015-12, pp. : 834-843

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stability of activated partial thromboplastin time (APTT) test under different storage conditions

By Awad Mohammed A.   Sharaf Eldeen Omar A.   Ibrahim Hoda A.  

Hematology, Vol. 11, Iss. 5-6, 2006-10 ,pp. : 311-315

Maney Publishing

Access to resources Recommend Favorite

Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin‐ activatable fibrinolysis inhibitor

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 4, 2015-08 ,pp. : 521-529

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Hirudin (Thrombin Specific Inhibitor) in Zebrafish Embryos: A Developmental Role for Thrombin

By Jagadeeswaran P.   Liu Y.C.   Eddy C.A.  

Blood Cells, Molecules, and Diseases, Vol. 23, Iss. 3, 1997-12 ,pp. : 410-414

Academic Press

Access to resources Recommend Favorite

Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemia

By Malyszko J.   Malyszko J.S.   Hryszko T.   Mysliwiec M.  

Transplantation Proceedings, Vol. 35, Iss. 6, 2003-09 ,pp. : 2219-2221

Elsevier

Access to resources Recommend Favorite

Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin

By Ofosu F.A.  

Transfusion and Apheresis Science, Vol. 28, Iss. 3, 2003-06 ,pp. : 265-268

Elsevier

Access to resources Recommend Favorite